High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana

Tropical Medicine and International Health

Volumn 10, Issue 12, 2005, Pages 1215-1218

  Menner, Nikolai ^a   Günther, Ingo ^b   Orawa, Helmut ^a   Roth, Andreas ^c,e   Rambajan, Indal ^d,f   Wagner, Jutta ^a   Hahn, Helmut ^a   Persaud, Shamdeo ^d,f   Ignatius, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Hospital Zehlendorf Heckeshorn   (Germany)

^d Ministry of Health Guyana   (Guyana)

^e Institute for Microbiology Immunology and Laboratory Medicine   (Germany)

^f Ministry of Health   (Guyana)

Author keywords

Guyana; Multidrug resistance; Tuberculosis

Indexed keywords

AGAR; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

DRUG RESISTANCE; EPIDEMIOLOGICAL PHENOMENA; TUBERCULOSIS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CULTURE MEDIUM; EPIDEMIOLOGICAL DATA; GUYANA; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTPATIENT DEPARTMENT; RISK FACTOR; SOLID;

ADULT; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; GUYANA; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; RISK FACTORS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

GUYANA; SOUTH AMERICA;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 29044441525     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01521.x     Document Type: Article

References (17)

1. Almeida da Silva PE, Osorio M, Reinhardt MC, de Souza Fonseca L & Dellagostin OA (2001) Drug resistance of strains of Mycobacterium tuberculosis isolated in Brazil. Microbes and Infection 13, 1111-1113.
2. Becerra MC, Freeman J, Bayona J et al. (2000) Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 4, 108-114.
3. Campos PE, Suarez PG, Sanchez J et al. (2003) Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerging Infectious Diseases 9, 1571-1578.
4. Espinal MA, Laszlo A, Simonsen L et al. (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New England Journal of Medicine 344, 1294-1303.
5. Evans KD, Nakasone AS, Sutherland PA, de la Maza LM & Peterson EM (1992) Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. Journal of Clinical Microbiology 30, 2427-2431.
6. Laserson KF, Osorio L, Sheppard JD et al. (1998) Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998. International Journal of Tuberculosis and Lung Disease 4, 673-683.
7. Mertz BL, Douce RW & Brito N (2000) Anti-tuberculosis drug resistance in two clinics in Ecuador. International Journal of Tuberculosis and Lung Disease 4, 115-117.
8. Mitnick C, Bayona J, Palacios E et al. (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine 348, 119-128.
9. Moore DA, Mendoza D, Gilman RH et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. Journal of Clinical Microbiology 42, 4432-4437.
10. Mukherjee JS, Rich ML, Socci AR et al. (2004) Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363, 474-481.
11. Pelly T, Moore DA, Gilman R & Evans C (2004) Recent tuberculosis advances in Latin America. Current Opinion in Infectious Diseases 17, 397-403.
12. Richter E, Weizenegger M, Rusch-Gerdes S & Niemann S (2003) Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates. Journal of Clinical Microbiology 41, 2672-2675.
13. Roth A, Reischl U, Streubel A et al. (2000) Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. Journal of Clinical Microbiology 38, 1094-1104.
14. Rusch-Gerdes S, Domehl C, Nardi G, Gismondo MR, Welscher HM & Pfyffer GE (1999) Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. Journal of Clinical Microbiology 37, 45-48.
15. Timperi R, Han LL, Sloutsky A et al. (2005) Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru. International Journal of Tuberculosis and Lung Disease 9, 175-180.
16. Wayne LG (1974) Simple pyrazinamidase and urease tests for routine identification of mycobacteria. American Review of Respiratory Disease 109, 147-151.
17. WHO (2005) WHO Report 2005: Global Tuberculosis Control - Surveillance, Planning, Financing. http://www.who.int/tb/publications/global_report/2005/ annex2/en/index2.html.